Prediction of atorvastatin plasmatic concentrations in healthy volunteers using integrated pharmacogenetics sequencing

Omar Fernando Cruz-Correa, Rafael Baltazar Reyes León-Cachón, Hugo Alberto Barrera-Saldaña, Xavier Soberón

    Research output: Contribution to journalArticlepeer-review

    14 Citations (Scopus)

    Abstract

    Aim: To use variants found by next-generation sequencing to predict atorvastatin plasmatic concentration profiles (AUC) in healthy volunteers. Subjects & methods: A total of 60 healthy Mexican volunteers were enrolled in this study. We used variants with a predicted functional effect across 20 genes involved in atorvastatin metabolism to construct a regression model using a support vector approach with a radial basis function kernel to predict AUC refining it afterwards in order to explain a greater extent of the variance. Results: The final support vector regression model using 60 variants (including six novel variants) explained 94.52% of the variance in atorvastatin AUC. Conclusion: An integrated analysis of several genes known to intervene in the different steps of metabolism is required to predict atorvastatin's AUC.

    Original languageEnglish
    Pages (from-to)121-131
    Number of pages11
    JournalPharmacogenomics
    Volume18
    Issue number2
    DOIs
    Publication statusPublished - 1 Jan 2017

    Bibliographical note

    Publisher Copyright:
    © 2017 Future Medicine Ltd.

    Copyright:
    Copyright 2017 Elsevier B.V., All rights reserved.

    All Science Journal Classification (ASJC) codes

    • Molecular Medicine
    • Genetics
    • Pharmacology

    Fingerprint

    Dive into the research topics of 'Prediction of atorvastatin plasmatic concentrations in healthy volunteers using integrated pharmacogenetics sequencing'. Together they form a unique fingerprint.

    Cite this